Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder. (March 2017)

• Record Type: Journal Article
• Authors: Joas, Erik; Karanti, Alina; Song, Jie; Goodwin, Guy M.; Lichtenstein, Paul; Landén, Mikael
• Is Part Of: British journal of psychiatry. Volume 210:Number 3(2017)
• Page Start: 197
• Page End: 202
• Publication Date: 2017-03
• Subjects: Psychiatry -- Periodicals; Psychology, Pathological -- Periodicals; 616.89005
• DOI: 10.1192/bjp.bp.116.187989
• Languages: English
• ISSNs: 0007-1250

Abstract

Abstract : Background: Clinical trials have examined the efficacy of drugs to prevent relapse in patients with bipolar disorder, however, their design often limits generalisation to routine clinical practice. Aims: To estimate the effectiveness of drugs used for maintenance treatment in bipolar disorder. Method: We used national registers to identify 35022 individuals diagnosed with bipolar disorder and information on lithium, valproate, carbamazepine, lamotrigine, quetiapine and olanzapine treatment from 2006 to 2009. The main outcome was psychiatric hospital admissions. We used stratified cox regression to compare periods on and off medication within the same individual. Results: Medication with lithium, valproate, lamotrigine, olanzapine and quetiapine was associated with reduced rates of admission to hospital. Lithium was more effective than quetiapine and olanzapine. The effects of specific drugs depended on the polarity of the mood episode. Conclusions: Our findings complement results from randomised controlled trails, but suggest that lithium is more effective than both quetiapine and olanzapine in routine clinical practice.